Status and influencing factors of treatment delay of rifampicin resistant tuberculosis patients, Guizhou, 2016-2022.

MLA

WANG Da-fu, et al. “Status and Influencing Factors of Treatment Delay of Rifampicin Resistant Tuberculosis Patients, Guizhou, 2016-2022.” Modern Preventive Medicine, vol. 51, no. 18, Sept. 2024, pp. 3410–15. EBSCOhost, https://doi.org/10.20043/j.cnki.MPM.202404101.

APA

WANG Da-fu, GUO Xue-li, MA Xiao-xue, WANG Yun, ZHOU Jiao-jiao, ZHOU Jian, LI Fu-dong, & LI Jin-lan. (2024). Status and influencing factors of treatment delay of rifampicin resistant tuberculosis patients, Guizhou, 2016-2022. Modern Preventive Medicine, 51(18), 3410–3415. https://doi.org/10.20043/j.cnki.MPM.202404101

Chicago

WANG Da-fu, GUO Xue-li, MA Xiao-xue, WANG Yun, ZHOU Jiao-jiao, ZHOU Jian, LI Fu-dong, and LI Jin-lan. 2024. “Status and Influencing Factors of Treatment Delay of Rifampicin Resistant Tuberculosis Patients, Guizhou, 2016-2022.” Modern Preventive Medicine 51 (18): 3410–15. doi:10.20043/j.cnki.MPM.202404101.